Literature DB >> 15677566

CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase.

Elizabeth A Williamson1, Ian K Williamson, Alexey M Chumakov, Alan D Friedman, H Phillip Koeffler.   

Abstract

C/EBPepsilon, a member of the CCAAT/enhancer binding protein family, is a transcription factor important in neutrophil differentiation. We have determined that it is phosphorylated on multiple serine and threonine residues and can be a target for phosphorylation by a number of kinases. We identified a threonine at amino acid 75, part of a consensus mitogen-activated protein (MAP) kinase site within the transactivation domain of C/EBPepsilon, as being phosphorylated only by p38 MAP kinase. Phosphorylation of this residue resulted in enhanced transcriptional activity on a myeloid-specific promoter in in vitro transient transfection reporter assays. We also determined that phosphorylation at Thr75 yielded a protein that was more effective at binding its cognate DNA sequence compared with the wild-type nonphosphorylated C/EBPepsilon. Stable expression of C/EBPepsilonT75A in interleukin 3 (IL-3)-dependent 32Dcl3 did not result in the up-regulation of expression of secondary granule genes compared with wild-type C/EBPepsilon or C/EBPepsilonT75D. Therefore we suggest that C/EBPepsilon is a target for p38 MAP kinase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677566      PMCID: PMC1895069          DOI: 10.1182/blood-2004-09-3708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction.

Authors:  W Ito; H Ishiguro; Y Kurosawa
Journal:  Gene       Date:  1991-06-15       Impact factor: 3.688

2.  Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase.

Authors:  S E Ross; R L Erickson; N Hemati; O A MacDougald
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding.

Authors:  C W Mahoney; J Shuman; S L McKnight; H C Chen; K P Huang
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

4.  Isolation, characterization and chromosomal localization of the human GADD153 gene.

Authors:  J S Park; J D Luethy; M G Wang; J Fargnoli; A J Fornace; O W McBride; N J Holbrook
Journal:  Gene       Date:  1992-07-15       Impact factor: 3.688

Review 5.  IL-6 and NF-IL6 in acute-phase response and viral infection.

Authors:  S Akira; T Kishimoto
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

6.  Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.

Authors:  T Nakajima; S Kinoshita; T Sasagawa; K Sasaki; M Naruto; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3.

Authors:  T S Juan; D R Wilson; M D Wilde; G J Darlington
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1.

Authors:  Adrian F Gombart; Scott H Kwok; Karen L Anderson; Yuji Yamaguchi; Bruce E Torbett; H Phillip Koeffler
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

9.  Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta.

Authors:  M Wegner; Z Cao; M G Rosenfeld
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

10.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  7 in total

1.  Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.

Authors:  Alexey M Chumakov; Agnes Silla; Elizabeth A Williamson; H Phillip Koeffler
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  C/EBPε participates in all-trans retinoic acid induction of PI3Kγ in U937 cells via an intronic matrix attachment region sequence.

Authors:  Rong Cai; Xia Cai; Bin Chen; Weirong Xu; Jian Lu
Journal:  Mol Biol Rep       Date:  2010-07-27       Impact factor: 2.316

3.  C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Authors:  Pierre Kyme; Nils H Thoennissen; Ching Wen Tseng; Gabriela B Thoennissen; Andrea J Wolf; Kenichi Shimada; Utz O Krug; Kunik Lee; Carsten Müller-Tidow; Wolfgang E Berdel; W David Hardy; Adrian F Gombart; H Phillip Koeffler; George Y Liu
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

4.  PLZF is a regulator of homeostatic and cytokine-induced myeloid development.

Authors:  Sergei Doulatov; Faiyaz Notta; Kim L Rice; Louise Howell; Arthur Zelent; Jonathan D Licht; John E Dick
Journal:  Genes Dev       Date:  2009-09-01       Impact factor: 11.361

5.  Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes.

Authors:  Ivan Nagaev; Maria Bokarewa; Andrej Tarkowski; Ulf Smith
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  LPS independent activation of the pro-inflammatory receptor Trem1 by C/EBPε in granulocytes.

Authors:  Hyung C Suh; Touati Benoukraf; Pavithra Shyamsunder; Tong Yin; Qi Cao; Jonathan Said; Stephen Lee; Ricky Lim; Henry Yang; Jacqueline Salotti; Peter F Johnson; Vikas Madan; H Phillip Koeffler
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

Review 7.  An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling.

Authors:  Jiahuai Han; Jianfeng Wu; John Silke
Journal:  F1000Res       Date:  2020-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.